NEWBURYPORT, MA — (Marketwired) — 12/09/13 — PCI Synthesis, Inc. (), a 15-year-old pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs) and other specialty chemical products, today announced a list of trends it thinks will impact the emerging biotech and generic drug industries in 2014.The FDA continues to expand its scope for oversight — most recently with a bill signed into law in November, the Drug Quality and Security Act. There-s
NEWBURYPORT, MA — (Marketwire) — 05/30/12 — PCI Synthesis, Inc. (), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, today announced that industry veteran Alexander Tretyakov has joined the company as Vice President of Research and Development.In this role, Tretyakov will provide technical leadership across the company, specifically in creating de novo synthetic schemes and ap
